دورية أكاديمية

Isolated limb perfusion with melphalan for melanoma.

التفاصيل البيبلوغرافية
العنوان: Isolated limb perfusion with melphalan for melanoma.
المؤلفون: Nieweg OE; Melanoma Institute Australia, North Sydney, NSW, Australia., Kroon BB
المصدر: Journal of surgical oncology [J Surg Oncol] 2014 Mar; Vol. 109 (4), pp. 332-7. Date of Electronic Publication: 2014 Jan 14.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE
أسماء مطبوعة: Publication: <2005-> : Hoboken, NJ : Wiley-Liss
Original Publication: New York, Plenum.
مواضيع طبية MeSH: Antineoplastic Agents, Alkylating/*administration & dosage , Chemotherapy, Cancer, Regional Perfusion/*methods , Melanoma/*drug therapy , Melphalan/*administration & dosage, Humans ; Melanoma/blood supply ; Melanoma/pathology ; Melanoma/surgery ; Randomized Controlled Trials as Topic
مستخلص: Isolated limb perfusion with melphalan is a well-established and effective treatment for inoperable melanoma metastases of the extremities, with an overall response rate of 80% and a complete response rate of 54%. The surgical technique is complex and serious morbidity can occur, but with attention to detail major side effects can be kept to a minimum. This article reviews the technique, results and other aspects of this sophisticated form of treatment.
(© 2014 Wiley Periodicals, Inc.)
فهرسة مساهمة: Keywords: limb perfusion; metastases; regional chemotherapy; review
المشرفين على المادة: 0 (Antineoplastic Agents, Alkylating)
Q41OR9510P (Melphalan)
تواريخ الأحداث: Date Created: 20140115 Date Completed: 20140403 Latest Revision: 20220408
رمز التحديث: 20221213
DOI: 10.1002/jso.23558
PMID: 24421252
قاعدة البيانات: MEDLINE
الوصف
تدمد:1096-9098
DOI:10.1002/jso.23558